SPRB — Spruce Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Spruce Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	157	89	79.1	96.3	38.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	160	91.9	83.6	102	44.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.79	1.65	1.4	1.18	0.934
Long Term Investments
Other Long Term Assets
Total Assets	163	126	85.6	104	45.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.76	8.87	12.4	24.5	15.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.5	15.1	17.2	27.4	16.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	149	111	68.5	76.5	28.8
Total Liabilities & Shareholders' Equity	163	126	85.6	104	45.2
Total Common Shares Outstanding